{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:46:07Z","timestamp":1780519567554,"version":"3.54.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T00:00:00Z","timestamp":1360108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12017-013-8219-0","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T03:59:12Z","timestamp":1360036752000},"page":"295-309","source":"Crossref","is-referenced-by-count":134,"title":["Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington\u2019s Disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Izaskun","family":"Villar-Men\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiraz","family":"Tyebji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Pereira-Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Albasanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairena","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Barrachina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"issue":"25","key":"8219_CR1","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1523\/JNEUROSCI.5695-09.2010","volume":"30","author":"N Assaife-Lopes","year":"2010","unstructured":"Assaife-Lopes, N., Sousa, V. C., Pereira, D. B., Ribeiro, J. A., Chao, M. V., & Sebasti\u00e3o, A. M. (2010). Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: Implications for neuromodulation. The Journal of Neuroscience, 30(25), 8468\u20138480.","journal-title":"The Journal of Neuroscience"},{"issue":"2","key":"8219_CR2","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","volume":"8","author":"M Ba\u00f1ez-Coronel","year":"2012","unstructured":"Ba\u00f1ez-Coronel, M., Porta, S., Kagerbauer, B., Mateu-Huertas, E., Pantano, L., Ferrer, I., et al. (2012). A pathogenic mechanism in Huntington\u2019s disease involves small CAG-repeated RNAs with neurotoxic activity. PLoS Genetics, 8(2), e1002481.","journal-title":"PLoS Genetics"},{"issue":"8","key":"8219_CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181af2e46","volume":"68","author":"M Barrachina","year":"2009","unstructured":"Barrachina, M., & Ferrer, I. (2009). DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. Journal of Neuropathology and Experimental Neurology, 68(8), 880\u2013891.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"3","key":"8219_CR4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2005.03169.x","volume":"94","author":"A Bauer","year":"2005","unstructured":"Bauer, A., Zilles, K., Matusch, A., Holzmann, C., Riess, O., & von H\u00f6rsten, S. (2005). Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington\u2019s disease mutation. Journal of Neurochemistry, 94(3), 639\u2013650.","journal-title":"Journal of Neurochemistry"},{"issue":"12","key":"8219_CR5","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","volume":"23","author":"D Blum","year":"2003","unstructured":"Blum, D., Galas, M. C., Pintor, A., Brouillet, E., Ledent, C., Muller, C. E., et al. (2003). A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: Implications for the neuroprotective potential of A2A antagonists. The Journal of Neuroscience, 23(12), 5361\u20135369.","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"8219_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/01677063.2010.503978","volume":"24","author":"J Brohede","year":"2010","unstructured":"Brohede, J., Rinde, M., Winblad, B., & Graff, C. (2010). A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease. Journal of Neurogenetics, 24(4), 179\u2013181.","journal-title":"Journal of Neurogenetics"},{"issue":"5","key":"8219_CR7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1471-4159.2009.06538.x","volume":"112","author":"SP Buira","year":"2010","unstructured":"Buira, S. P., Albasanz, J. L., Dentesano, G., Moreno, J., Mart\u00edn, M., Ferrer, I., et al. (2010a). DNA methylation regulates adenosine A(2A) receptor cell surface expression levels. Journal of Neurochemistry, 112(5), 1273\u20131285.","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"8219_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-4159.2010.06928.x","volume":"115","author":"SP Buira","year":"2010","unstructured":"Buira, S. P., Dentesano, G., Albasanz, J. L., Moreno, J., Mart\u00edn, M., Ferrer, I., et al. (2010b). DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain. Journal of Neurochemistry, 115(1), 283\u2013295.","journal-title":"Journal of Neurochemistry"},{"issue":"Pt 5","key":"8219_CR9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","volume":"127","author":"F Calon","year":"2004","unstructured":"Calon, F., Dridi, M., Hornykiewicz, O., B\u00e9dard, P. J., Rajput, A. H., & Di Paolo, T. (2004). Increased adenosine A2A receptors in the brain of Parkinson\u2019s disease patients with dyskinesias. Brain, 127(Pt 5), 1075\u20131084.","journal-title":"Brain"},{"issue":"1386","key":"8219_CR10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","volume":"354","author":"JH Cha","year":"1999","unstructured":"Cha, J. H., Frey, A. S., Alsdorf, S. A., Kerner, J. A., Kosinski, C. M., Mangiarini, L., et al. (1999). Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philosophical Transactions of the Royal Society of London. Series B, Biological Science, 354(1386), 981\u2013989.","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Science"},{"issue":"2","key":"8219_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","volume":"22","author":"AS Chen-Plotkin","year":"2006","unstructured":"Chen-Plotkin, A. S., Sadri-Vakili, G., Yohrling, G. J., Braveman, M. W., Benn, C. L., Glajch, K. E., et al. (2006). Decreased association of the transcription factor Sp1 with genes downregulated in Huntington\u2019s disease. Neurobiology of Disease, 22(2), 233\u2013241.","journal-title":"Neurobiology of Disease"},{"issue":"16","key":"8219_CR12","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddp230","volume":"18","author":"MC Chiang","year":"2009","unstructured":"Chiang, M. C., Chen, H. M., Lai, H. L., Chen, H. W., Chou, S. Y., Chen, C. M., et al. (2009). The A2A adenosine receptor rescues the urea cycle deficiency of Huntington\u2019s disease by enhancing the activity of the ubiquitin-proteasome system. Human Molecular Genetics, 18(16), 2929\u20132942.","journal-title":"Human Molecular Genetics"},{"issue":"14","key":"8219_CR13","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","volume":"280","author":"MC Chiang","year":"2005","unstructured":"Chiang, M. C., Lee, Y. C., Huang, C. L., & Chern, Y. (2005). cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. The Journal of Biological Chemistry, 280(14), 14331\u201314340.","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"8219_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mcn.2011.11.003","volume":"49","author":"YJ Choi","year":"2012","unstructured":"Choi, Y. J., Kim, S. I., Lee, J. W., Kwon, Y. S., Lee, H. J., Kim, S. S., et al. (2012). Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death. Molecular and Cellular Neurosciences, 49(2), 127\u2013137.","journal-title":"Molecular and Cellular Neurosciences"},{"issue":"4","key":"8219_CR15","first-page":"560","volume":"30","author":"SY Cong","year":"2005","unstructured":"Cong, S. Y., Pepers, B. A., Evert, B. O., Rubinsztein, D. C., Roos, R. A., van Ommen, G. J., et al. (2005). Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Molecular and Cellular Neurosciences, 30(4), 560\u2013571.","journal-title":"Molecular and Cellular Neurosciences"},{"issue":"4","key":"8219_CR16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12017-011-8163-9","volume":"13","author":"L Boni de","year":"2011","unstructured":"de Boni, L., Tierling, S., Roeber, S., Walter, J., Giese, A., & Kretzschmar, H. A. (2011). Next-generation sequencing reveals regional differences of the \u03b1-synuclein methylation state independent of Lewy body disease. NeuroMolecular Medicine, 13(4), 310\u2013320.","journal-title":"NeuroMolecular Medicine"},{"issue":"3","key":"8219_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00001756-200303030-00003","volume":"14","author":"J Deckert","year":"2003","unstructured":"Deckert, J., Brenner, M., Durany, N., Z\u00f6chling, R., Paulus, W., Ransmayr, G., et al. (2003). Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. NeuroReport, 14(3), 313\u2013316.","journal-title":"NeuroReport"},{"issue":"3","key":"8219_CR18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","volume":"35","author":"CM Dhaenens","year":"2009","unstructured":"Dhaenens, C. M., Burnouf, S., Simonin, C., Van Brussel, E., Duhamel, A., Defebvre, L., et al. (2009). A genetic variation in the ADORA2A gene modifies age at onset in Huntington\u2019s disease. Neurobiology of Disease, 35(3), 474\u2013476.","journal-title":"Neurobiology of Disease"},{"issue":"4","key":"8219_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","volume":"13","author":"J Feng","year":"2010","unstructured":"Feng, J., Zhou, Y., Campbell, S. L., Le, T., Li, E., Sweatt, J. D., et al. (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nature Neuroscience, 13(4), 423\u2013430.","journal-title":"Nature Neuroscience"},{"issue":"1\u20132","key":"8219_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer, I., Goutan, E., Mar\u00edn, C., Rey, M. J., & Ribalta, T. (2000). Brain-derived neurotrophic factor in Huntington disease. Brain Research, 866(1\u20132), 257\u2013261.","journal-title":"Brain Research"},{"issue":"3","key":"8219_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10561-008-9077-0","volume":"9","author":"I Ferrer","year":"2008","unstructured":"Ferrer, I., Martinez, A., Boluda, S., Parchi, P., & Barrachina, M. (2008). Brain banks: Benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell and Tissue Banking, 9(3), 181\u2013194.","journal-title":"Cell and Tissue Banking"},{"issue":"4","key":"8219_CR22","first-page":"527","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm, B. B., Ijzerman, A. P., Jacobson, K. A., Klotz, K. N., & Linden, J. (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews, 53(4), 527\u2013552.","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"8219_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","volume":"17","author":"M Gianfriddo","year":"2004","unstructured":"Gianfriddo, M., Melani, A., Turchi, D., Giovannini, M. G., & Pedata, F. (2004). Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow. Neurobiology of Disease, 17(1), 77\u201388.","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"8219_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gin\u00e9s","year":"2006","unstructured":"Gin\u00e9s, S., Bosch, M., Marco, S., Gavald\u00e0, N., D\u00edaz-Hern\u00e1ndez, M., Lucas, J. J., et al. (2006). Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. The European Journal of Neuroscience, 23(3), 649\u2013658.","journal-title":"The European Journal of Neuroscience"},{"issue":"21","key":"8219_CR25","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt, A., Saavedra, A., Carreton, O., Xifro, X., Alberch, J., & Perez-Navarro, E. (2011). Increased PKA signaling disrupts recognition memory and spatial memory: Role in Huntington\u2019s disease. Human Molecular Genetics, 20(21), 4232\u20134247.","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"8219_CR26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass, M., Dragunow, M., & Faull, R. L. (2000). The pattern of neurodegeneration in Huntington\u2019s disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience, 97(3), 505\u2013519.","journal-title":"Neuroscience"},{"issue":"12","key":"8219_CR27","doi-asserted-by":"crossref","first-page":"e15367","DOI":"10.1371\/journal.pone.0015367","volume":"5","author":"D Globisch","year":"2010","unstructured":"Globisch, D., M\u00fcnzel, M., M\u00fcller, M., Michalakis, S., Wagner, M., Koch, S., et al. (2010). Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE, 5(12), e15367.","journal-title":"PLoS ONE"},{"issue":"10","key":"8219_CR28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/nn.2900","volume":"14","author":"JU Guo","year":"2011","unstructured":"Guo, J. U., Ma, D. K., Mo, H., Ball, M. P., Jang, M. H., Bonaguidi, M. A., et al. (2011a). Neuronal activity modifies the DNA methylation landscape in the adult brain. Nature Neuroscience, 14(10), 1345\u20131351.","journal-title":"Nature Neuroscience"},{"issue":"3","key":"8219_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","volume":"145","author":"JU Guo","year":"2011","unstructured":"Guo, J. U., Su, Y., Zhong, C., Ming, G. L., & Song, H. (2011b). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell, 145(3), 423\u2013434.","journal-title":"Cell"},{"issue":"6","key":"8219_CR30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., et al. (2006). Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Human Molecular Genetics, 15(6), 965\u2013977.","journal-title":"Human Molecular Genetics"},{"issue":"6","key":"8219_CR31","doi-asserted-by":"crossref","first-page":"e20934","DOI":"10.1371\/journal.pone.0020934","volume":"6","author":"NK Huang","year":"2011","unstructured":"Huang, N. K., Lin, J. H., Lin, J. T., Lin, C. I., Liu, E. M., Lin, C. J., et al. (2011). A new drug design targeting the adenosinergic system for Huntington\u2019s disease. PLoS ONE, 6(6), e20934.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"8219_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jneumeth.2006.02.018","volume":"156","author":"HS Huang","year":"2006","unstructured":"Huang, H. S., Matevossian, A., Jiang, Y., & Akbarian, S. (2006). Chromatin immunoprecipitation in postmortem brain. Journal of Neuroscience Methods, 156(1\u20132), 284\u2013292.","journal-title":"Journal of Neuroscience Methods"},{"issue":"7","key":"8219_CR33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02988643","volume":"16","author":"K Ishiwata","year":"2002","unstructured":"Ishiwata, K., Ogi, N., Hayakawa, N., Oda, K., Nagaoka, T., Toyama, H., et al. (2002). Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging. Annals of Nuclear Medicine, 16(7), 467\u2013475.","journal-title":"Annals of Nuclear Medicine"},{"issue":"11","key":"8219_CR34","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/nar\/gkq223","volume":"38","author":"SG Jin","year":"2010","unstructured":"Jin, S. G., Kadam, S., & Pfeifer, G. P. (2010). Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Research, 38(11), e125.","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"8219_CR35","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1093\/nar\/gkr120","volume":"39","author":"SG Jin","year":"2011","unstructured":"Jin, S. G., Wu, X., Li, A. X., & Pfeifer, G. P. (2011). Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Research, 39(12), 5015\u20135024.","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"8219_CR36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. (2012). Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nature Reviews Genetics, 13(7), 484\u2013492.","journal-title":"Nature Reviews Genetics"},{"issue":"18","key":"8219_CR37","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed, A., Schmitt, I., Kaut, O., & W\u00fcllner, U. (2010). Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. The Journal of Neuroscience, 30(18), 6355\u20136359.","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"8219_CR38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsmb.2372","volume":"19","author":"T Khare","year":"2012","unstructured":"Khare, T., Pai, S., Koncevicius, K., Pal, M., Kriukiene, E., Liutkeviciute, Z., et al. (2012). 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nature Structural & Molecular Biology, 19(10), 1037\u20131043.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"5929","key":"8219_CR39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","volume":"324","author":"S Kriaucionis","year":"2009","unstructured":"Kriaucionis, S., & Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 324(5929), 929\u2013930.","journal-title":"Science"},{"issue":"15","key":"8219_CR40","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn, A., Goldstein, D. R., Hodges, A., Strand, A. D., Sengstag, T., Kooperberg, C., et al. (2007). Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Human Molecular Genetics, 16(15), 1845\u20131861.","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"8219_CR41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li, S. H., Cheng, A. L., Zhou, H., Lam, S., Rao, M., Li, H., et al. (2002). Interaction of Huntington disease protein with transcriptional activator Sp1. Molecular and Cellular Biology, 22(5), 1277\u20131287.","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"8219_CR42","first-page":"155","volume":"16","author":"ED London","year":"1981","unstructured":"London, E. D., Yamamura, H. I., Bird, E. D., & Coyle, J. T. (1981). Decreased receptor-binding sites for kainic acid in brains of patients with Huntington\u2019s disease. Biological Psychiatry, 16(2), 155\u2013162.","journal-title":"Biological Psychiatry"},{"issue":"3","key":"8219_CR43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87(3), 493\u2013506.","journal-title":"Cell"},{"issue":"3","key":"8219_CR44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-4522(91)90038-P","volume":"42","author":"MI Martinez-Mir","year":"1991","unstructured":"Martinez-Mir, M. I., Probst, A., & Palacios, J. M. (1991). Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease. Neuroscience, 42(3), 697\u2013706.","journal-title":"Neuroscience"},{"issue":"11","key":"8219_CR45","doi-asserted-by":"crossref","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"L Matsumoto","year":"2010","unstructured":"Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., et al. (2010). CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson\u2019s disease. PLoS ONE, 5(11), e15522.","journal-title":"PLoS ONE"},{"issue":"2","key":"8219_CR46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.nbd.2010.09.021","volume":"41","author":"S Mievis","year":"2011","unstructured":"Mievis, S., Blum, D., & Ledent, C. (2011). A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington\u2019s disease. Neurobiology of Disease, 41(2), 570\u2013576.","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"8219_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.2560","volume":"13","author":"CA Miller","year":"2010","unstructured":"Miller, C. A., Gavin, C. F., White, J. A., Parrish, R. R., Honasoge, A., Yancey, C. R., et al. (2010). Cortical DNA methylation maintains remote memory. Nature Neuroscience, 13(6), 664\u2013666.","journal-title":"Nature Neuroscience"},{"issue":"6","key":"8219_CR48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2007.02.022","volume":"53","author":"CA Miller","year":"2007","unstructured":"Miller, C. A., & Sweatt, J. D. (2007). Covalent modification of DNA regulates memory formation. Neuron, 53(6), 857\u2013869.","journal-title":"Neuron"},{"issue":"2","key":"8219_CR49","doi-asserted-by":"crossref","first-page":"e17338","DOI":"10.1371\/journal.pone.0017338","volume":"6","author":"M Mishina","year":"2011","unstructured":"Mishina, M., Ishiwata, K., Naganawa, M., Kimura, Y., Kitamura, S., Suzuki, M., et al. (2011). Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson\u2019s disease patients. PLoS ONE, 6(2), e17338.","journal-title":"PLoS ONE"},{"issue":"31","key":"8219_CR50","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1002\/anie.201002033","volume":"49","author":"M M\u00fcnzel","year":"2010","unstructured":"M\u00fcnzel, M., Globisch, D., Br\u00fcckl, T., Wagner, M., Welzmiller, V., Michalakis, S., et al. (2010). Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angewandte Chemie (International ed. in English), 49(31), 5375\u20135377.","journal-title":"Angewandte Chemie (International ed. in English)"},{"issue":"29","key":"8219_CR51","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1002\/anie.201101547","volume":"50","author":"M M\u00fcnzel","year":"2011","unstructured":"M\u00fcnzel, M., Globisch, D., & Carell, T. (2011). 5-Hydroxymethylcytosine, the sixth base of the genome. Angewandte Chemie (International ed. in English), 50(29), 6460\u20136468.","journal-title":"Angewandte Chemie (International ed. in English)"},{"issue":"5512","key":"8219_CR52","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora, F. C, Jr, Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., et al. (2001). Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 291(5512), 2423\u20132428.","journal-title":"Science"},{"issue":"1","key":"8219_CR53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2011.08.005","volume":"232","author":"M Orr\u00fa","year":"2011","unstructured":"Orr\u00fa, M., Zanoveli, J. M., Quiroz, C., Nguyen, H. P., Guitart, X., & Ferr\u00e9, S. (2011). Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease. Experimental Neurology, 232(1), 76\u201380.","journal-title":"Experimental Neurology"},{"issue":"12","key":"8219_CR54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.32.12.1391","volume":"32","author":"JB Penney Jr","year":"1982","unstructured":"Penney, J. B, Jr, & Young, A. B. (1982). Quantitative autoradiography of neurotransmitter receptors in Huntington disease. Neurology, 32(12), 1391\u20131395.","journal-title":"Neurology"},{"issue":"3","key":"8219_CR55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2008.09.010","volume":"32","author":"HC Pieper","year":"2008","unstructured":"Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., & W\u00fcllner, U. (2008). Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability. Neurobiology of Disease, 32(3), 521\u2013527.","journal-title":"Neurobiology of Disease"},{"issue":"7","key":"8219_CR56","doi-asserted-by":"crossref","first-page":"e22585","DOI":"10.1371\/journal.pone.0022585","volume":"6","author":"M Pietrzak","year":"2011","unstructured":"Pietrzak, M., Rempala, G., Nelson, P. T., Zheng, J. J., & Hetman, M. (2011). Epigenetic silencing of nucleolar rRNA genes in Alzheimer\u2019s disease. PLoS ONE, 6(7), e22585.","journal-title":"PLoS ONE"},{"issue":"15","key":"8219_CR57","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","volume":"14","author":"P Popoli","year":"2008","unstructured":"Popoli, P., Blum, D., Domenici, M. R., Burnouf, S., & Chern, Y. (2008). A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington\u2019s disease. Current Pharmaceutical Design, 14(15), 1500\u20131511.","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"8219_CR58","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","volume":"22","author":"P Popoli","year":"2002","unstructured":"Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., P\u00e8zzola, A., et al. (2002). Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: Possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. The Journal of Neuroscience, 22(5), 1967\u20131975.","journal-title":"The Journal of Neuroscience"},{"issue":"15","key":"8219_CR59","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner, A., Albin, R. L., Anderson, K. D., D\u2019Amato, C. J., Penney, J. B., & Young, A. B. (1988). Differential loss of striatal projection neurons in Huntington disease. Proceedings of the National Academy of Sciences of the United States of America, 85(15), 5733\u20135737.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"8219_CR60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","volume":"132","author":"EK Richfield","year":"1991","unstructured":"Richfield, E. K., O\u2019Brien, C. F., Eskin, T., & Shoulson, I. (1991). Heterogeneous dopamine receptor changes in early and late Huntington\u2019s disease. Neuroscience Letters, 132(1), 121\u2013126.","journal-title":"Neuroscience Letters"},{"issue":"2","key":"8219_CR61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cdd.2009.127","volume":"17","author":"A Saavedra","year":"2010","unstructured":"Saavedra, A., Garcia-Martinez, J. M., Xifro, X., Giralt, A., Torres-Peraza, J. F., Canals, J. M., et al. (2010). PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3\u00a0K\/Akt pro-survival pathway in Huntington\u2019s disease striatum. Cell Death and Differentiation, 17(2), 324\u2013335.","journal-title":"Cell Death and Differentiation"},{"issue":"5","key":"8219_CR62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","volume":"83","author":"SN Schiffmann","year":"2007","unstructured":"Schiffmann, S. N., Fisone, G., Moresco, R., Cunha, R. A., & Ferr\u00e9, S. (2007). Adenosine A2A receptors and basal ganglia physiology. Progress in Neurobiology, 83(5), 277\u2013292.","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"8219_CR63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt.1732","volume":"29","author":"CX Song","year":"2011","unstructured":"Song, C. X., Szulwach, K. E., Fu, Y., Dai, Q., Yi, C., Li, X., et al. (2011). Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nature Biotechnology, 29(1), 68\u201372.","journal-title":"Nature Biotechnology"},{"issue":"12","key":"8219_CR64","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y. Z., Gohler, H., et al. (2000). The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proceeding of the National Academy of Sciences of the United States of America, 97(12), 6763\u20136768.","journal-title":"Proceeding of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"8219_CR65","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.182.3.1500","volume":"182","author":"K Sunahori","year":"2009","unstructured":"Sunahori, K., Juang, Y. T., & Tsokos, G. C. (2009). Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. Journal of Immunology, 182(3), 1500\u20131508.","journal-title":"Journal of Immunology"},{"issue":"6","key":"8219_CR66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","volume":"9","author":"MM Suzuki","year":"2008","unstructured":"Suzuki, M. M., & Bird, A. (2008). DNA methylation landscapes: Provocative insights from epigenomics. Nature Review Genetics, 9(6), 465\u2013476.","journal-title":"Nature Review Genetics"},{"issue":"12","key":"8219_CR67","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/nn.2959","volume":"14","author":"KE Szulwach","year":"2011","unstructured":"Szulwach, K. E., Li, X., Li, Y., Song, C. X., Wu, H., Dai, Q., et al. (2011). 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nature Neuroscience, 14(12), 1607\u20131616.","journal-title":"Nature Neuroscience"},{"issue":"4","key":"8219_CR68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10048-010-0248-3","volume":"11","author":"E Taherzadeh-Fard","year":"2010","unstructured":"Taherzadeh-Fard, E., Saft, C., Wieczorek, S., Epplen, J. T., & Arning, L. (2010). Age at onset in Huntington\u2019s disease: Replication study on the associations of ADORA2A, HAP1 and OGG1. Neurogenetics, 11(4), 435\u2013439.","journal-title":"Neurogenetics"},{"issue":"5929","key":"8219_CR69","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324(5929), 930\u2013935.","journal-title":"Science"},{"key":"8219_CR70","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1100\/tsw.2010.164","volume":"10","author":"MT Tebano","year":"2010","unstructured":"Tebano, M. T., Martire, A., Chiodi, V., Ferrante, A., & Popoli, P. (2010). Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: A possible key mechanism in the pathophysiology of Huntington\u2019s disease. ScientificWorldJournal, 10, 1768\u20131782.","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"8219_CR71","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell, 72(6), 971\u2013983.","journal-title":"Cell"},{"issue":"12","key":"8219_CR72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/0008-5472.CAN-06-3123","volume":"67","author":"V Valinluck","year":"2007","unstructured":"Valinluck, V., & Sowers, L. C. (2007). Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Research, 67(12), 946\u2013950.","journal-title":"Cancer Research"},{"issue":"14","key":"8219_CR73","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/nar\/gkh739","volume":"32","author":"V Valinluck","year":"2004","unstructured":"Valinluck, V., Tsai, H. H., Rogstad, D. K., Burdzy, A., Bird, A., & Sowers, L. C. (2004). Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Research, 32(14), 4100\u20134108.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"8219_CR74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1212\/WNL.32.1.63","volume":"32","author":"PC Ness Van","year":"1982","unstructured":"Van Ness, P. C., Watkins, A. E., Bergman, M. O., Tourtellotte, W. W., & Olsen, R. W. (1982). Gamma-Aminobutyric acid receptors in normal human brain and Huntington disease. Neurology, 32(1), 63\u201368.","journal-title":"Neurology"},{"issue":"1","key":"8219_CR75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2007.03.011","volume":"27","author":"K Varani","year":"2007","unstructured":"Varani, K., Bachoud-L\u00e9vi, A. C., Mariotti, C., Tarditi, A., Abbracchio, M. P., Gasperi, V., et al. (2007). Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington\u2019s disease stages. Neurobiology of Disease, 27(1), 36\u201343.","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"8219_CR76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1096\/fj.09-141044","volume":"24","author":"K Varani","year":"2010","unstructured":"Varani, K., Vincenzi, F., Tosi, A., Gessi, S., Casetta, I., Granieri, G., et al. (2010). A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson\u2019s disease. FASEB J, 24(2), 587\u2013598.","journal-title":"FASEB J"},{"issue":"1","key":"8219_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel, J. P. (2008). Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathologica, 115(1), 55\u201369.","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"8219_CR78","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., & Richardson, E. P, Jr. (1985). Neuropathological classification of Huntington\u2019s disease. Journal of Neuropathology and Experimental Neurology, 44(6), 559\u2013577.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"4","key":"8219_CR79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng1990","volume":"39","author":"M Weber","year":"2007","unstructured":"Weber, M., Hellmann, I., Stadler, M. B., Ramos, L., P\u00e4\u00e4bo, S., Rebhan, M., et al. (2007). Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genetics, 39(4), 457\u2013466.","journal-title":"Nature Genetics"},{"issue":"2","key":"8219_CR80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410180207","volume":"18","author":"PJ Whitehouse","year":"1985","unstructured":"Whitehouse, P. J., Trifiletti, R. R., Jones, B. E., Folstein, S., Price, D. L., Snyder, S. H., et al. (1985). Neurotransmitter receptor alterations in Huntington\u2019s disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Annals of Neurology, 18(2), 202\u2013210.","journal-title":"Annals of Neurology"},{"issue":"11","key":"8219_CR81","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/epi.6.11.17876","volume":"6","author":"Y Xin","year":"2011","unstructured":"Xin, Y., O\u2019Donnell, A. H., Ge, Y., Chanrion, B., Milekic, M., Rosoklija, G., et al. (2011). Role of CpG context and content in evolutionary signatures of brain DNA methylation. Epigenetics, 6(11), 1308\u20131318.","journal-title":"Epigenetics"},{"issue":"11","key":"8219_CR82","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/j.1460-9568.2008.06532.x","volume":"28","author":"M Yossifoff","year":"2008","unstructured":"Yossifoff, M., Kisliouk, T., & Meiri, N. (2008). Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter. The European Journal of Neuroscience, 28(11), 2267\u20132277.","journal-title":"The European Journal of Neuroscience"},{"issue":"4868","key":"8219_CR83","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","volume":"241","author":"AB Young","year":"1988","unstructured":"Young, A. B., Greenamyre, J. T., Hollingsworth, Z., Albin, R., D\u2019Amato, C., Shoulson, I., et al. (1988). NMDA receptor losses in putamen from patients with Huntington\u2019s disease. Science, 241(4868), 981\u2013983.","journal-title":"Science"},{"issue":"1\u20132","key":"8219_CR84","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainres.2003.11.072","volume":"2004","author":"L Yu","year":"2004","unstructured":"Yu, L., Frith, M. C., Suzuki, Y., Peterfreund, R. A., Gearan, T., Sugano, S., et al. (2004). Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Research, 2004(1\u20132), 156\u2013173.","journal-title":"Brain Research"},{"issue":"8","key":"8219_CR85","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","volume":"11","author":"ZX Yu","year":"2002","unstructured":"Yu, Z. X., Li, S. H., Nguyen, H. P., & Li, X. J. (2002). Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Human Molecular Genetics, 11(8), 905\u2013914.","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"8219_CR86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008). Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathology, 18(2), 225\u2013238.","journal-title":"Brain Pathology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-013-8219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-013-8219-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-013-8219-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T03:36:32Z","timestamp":1562643392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-013-8219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,6]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["8219"],"URL":"https:\/\/doi.org\/10.1007\/s12017-013-8219-0","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,6]]}}}